Cargando…
P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY-RELATED CLONAL HEMATOPOIESIS
Autores principales: | Uryu, Hidetaka, Saeki, Koichi, Nangalia, Jyoti, Chapman, Michael, Zhao, LI, Hsu, Joanne, Bueso-Ramos, Carlos, Chen, Shujuan, Yang, Hui, Dinardo, Courtney, Daver, Naval, Colla, Simona, Ganan-Gomez, Irene, Zhang, Jianhua, Song, Xingzhi, Thompson, Erika, Tang, Hongli, Orlowski, Robert Z, Champlin, Richard E., Qazilbash, Muzaffar H., Shpall, Elizabeth J., Futreal, Andrew, Garcia-Manero, Guillermo, Haeno, Hiroshi, Takahashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430513/ http://dx.doi.org/10.1097/01.HS9.0000972208.18169.8b |
Ejemplares similares
-
Pre-leukemic clonal hematopoiesis and the risk of therapy-related
myeloid neoplasms: a case-control study
por: Takahashi, Koichi, et al.
Publicado: (2016) -
Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017) -
Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023) -
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
por: Hsu, Joanne I., et al.
Publicado: (2018) -
PB2481: OUTCOMES OF INDIVIDUALS WITH CLONAL HEMATOPOIESIS EVALUATED AT A CANCER CENTER
por: Chien, Kelly, et al.
Publicado: (2023)